Renqi Xu

970 total citations · 1 hit paper
9 papers, 727 citations indexed

About

Renqi Xu is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Renqi Xu has authored 9 papers receiving a total of 727 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Oncology and 1 paper in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Renqi Xu's work include Peptidase Inhibition and Analysis (6 papers), Ubiquitin and proteasome pathways (6 papers) and Protein Degradation and Inhibitors (6 papers). Renqi Xu is often cited by papers focused on Peptidase Inhibition and Analysis (6 papers), Ubiquitin and proteasome pathways (6 papers) and Protein Degradation and Inhibitors (6 papers). Renqi Xu collaborates with scholars based in United States and Poland. Renqi Xu's co-authors include Longchuan Bai, Bo Wen, Duxin Sun, Jennifer L. Meagher, Jeanne A. Stuckey, Donna McEachern, Mi Wang, Shaomeng Wang, Chao‐Yie Yang and Krishnapriya Chinnaswamy and has published in prestigious journals such as Cancer Cell, Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Renqi Xu

9 papers receiving 723 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Potent and Selective Small-Molecule Degrader of STAT3 Achieves Complete Tumor Regression In Vivo

2019 440 citations Longchuan Bai, Haibin Zhou et al. Cancer Cell profile →

Peers

Countries citing papers authored by Renqi Xu

Since Specialization

Citations

This map shows the geographic impact of Renqi Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Renqi Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Renqi Xu more than expected).

Fields of papers citing papers by Renqi Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Renqi Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Renqi Xu. The network helps show where Renqi Xu may publish in the future.

Co-authorship network of co-authors of Renqi Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Renqi Xu. A scholar is included among the top collaborators of Renqi Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Renqi Xu. Renqi Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

#	Work	Indexed citations
1	Discovery of AK-1690: A Potent and Highly Selective STAT6 PROTAC Degrader 2024 ·Journal of Medicinal Chemistry ·(unknown), Yiqing Yang, Longchuan Bai, Mi Wang, Renqi Xu, (unknown), Krishnapriya Chinnaswamy, Hoda Metwally, Yu Wang, Donna McEachern, Jelena Tošović, Chao‐Yie Yang, Paul D. Kirchhoff, Jennifer L. Meagher, Jeanne A. Stuckey, Shaomeng Wang	9
2	Discovery of SD-436: A Potent, Highly Selective and Efficacious STAT3 PROTAC Degrader Capable of Achieving Complete and Long-Lasting Tumor Regression 2024 ·Journal of Medicinal Chemistry ·Renqi Xu, Haibin Zhou, Longchuan Bai, Donna McEachern, (unknown), (unknown), Mi Wang, Jelena Tošović, Chao‐Yie Yang, Krishnapriya Chinnaswamy, Jennifer L. Meagher, Jeanne A. Stuckey, Cai Liu, (unknown), Bo Wen, Duxin Sun, Shaomeng Wang	9
3	Abstract 6513: Discovery and characterization of a KRASG12C/D/V degrader with potent anti-tumor activity in KRASmut-driven preclinical models 2024 ·Cancer Research ·Zhengqing Li, Renqi Xu, Xiaofeng Yang, (unknown), Xiaoqiang Kong, Haibo Chen, Yongqing Sun, Ying Zhao, Jing Guo, (unknown), Han Han, Xiaoyun Liu, (unknown), Lieming Ding, Quan Zhou, Hao Wu, Jia‐Bing Wang	2
4	Abstract 6512: BPI-501836: A highly potent small molecule inhibitor targeting KRASG12D mutation 2024 ·Cancer Research ·Yang Xiang, Lu Yuan, Renqi Xu, Xiaoqiang Kong, Yongqing Sun, (unknown), Xiaoyun Liu, (unknown), Haibo Chen, Yanju Liu, Jialing Sun, Han Han, (unknown), Jing Guo, (unknown), Quan Zhou, Lieming Ding, Hao Wu, Jiabing Wang	2
5	A selective small-molecule STAT5 PROTAC degrader capable of achieving tumor regression in vivo 2023 ·Nature Chemical Biology ·(unknown), Longchuan Bai, Mi Wang, Donna McEachern, Jennifer L. Meagher, Renqi Xu, Yu Wang, Wei Jiang, Hoda Metwally, Paul D. Kirchhoff, (unknown), Hui Jiang, (unknown), Bo Wen, Duxin Sun, Jeanne A. Stuckey, Shaomeng Wang	40
6	Discovery of a Potent and Selective STAT5 PROTAC Degrader with Strong Antitumor Activity In Vivo in Acute Myeloid Leukemia 2023 ·Journal of Medicinal Chemistry ·(unknown), Longchuan Bai, Mi Wang, Donna McEachern, Jennifer L. Meagher, Renqi Xu, Paul D. Kirchhoff, Bo Wen, Duxin Sun, Jeanne A. Stuckey, Shaomeng Wang	20
7	SD-91 as A Potent and Selective STAT3 Degrader Capable of Achieving Complete and Long-Lasting Tumor Regression 2021 ·ACS Medicinal Chemistry Letters ·Haibin Zhou, Longchuan Bai, Renqi Xu, Donna McEachern, Krishnapriya Chinnaswamy, (unknown), Bo Wen, Mi Wang, Chao‐Yie Yang, Jennifer L. Meagher, Duxin Sun, Jeanne A. Stuckey, Shaomeng Wang	37
8	A Potent and Selective Small-Molecule Degrader of STAT3 Achieves Complete Tumor Regression In Vivo breakdown → 2019 ·Cancer Cell ·Longchuan Bai, Haibin Zhou, Renqi Xu, Yujun Zhao, Krishnapriya Chinnaswamy, Donna McEachern, Jianyong Chen, Chao‐Yie Yang, Zhaomin Liu, Mi Wang, Liu Liu, Hui Jiang, Bo Wen, Praveen Kumar, Jennifer L. Meagher, Duxin Sun, Jeanne A. Stuckey, Shaomeng Wang	440
9	Structure-Based Discovery of SD-36 as a Potent, Selective, and Efficacious PROTAC Degrader of STAT3 Protein 2019 ·Journal of Medicinal Chemistry ·Haibin Zhou, Longchuan Bai, Renqi Xu, Yujun Zhao, Jianyong Chen, Donna McEachern, Krishnapriya Chinnaswamy, Bo Wen, Lipeng Dai, Praveen Kumar, Chao‐Yie Yang, Zhaomin Liu, Mi Wang, Liu Liu, Jennifer L. Meagher, Yi Han, Duxin Sun, Jeanne A. Stuckey, Shaomeng Wang	168

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact